Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Monkeypox Vaccine and Treatment Market, by Region, 2019-2029 (USD Million)
1.2.2. Monkeypox Vaccine and Treatment Market, by Product, 2019-2029 (USD Million)
1.2.3. Monkeypox Vaccine and Treatment Market, by Gender, 2019-2029 (USD Million)
1.2.4. Monkeypox Vaccine and Treatment Market, by Route of Administration, 2019-2029 (USD Million)
1.2.5. Monkeypox Vaccine and Treatment Market, by End Use, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Monkeypox Vaccine and Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Monkeypox Vaccine and Treatment Market Dynamics
3.1. Monkeypox Vaccine and Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence and prevalence of Monkeypox
3.1.1.2. Government initiatives to combat an outbreak of monkeypox
3.1.2. Market Challenges
3.1.2.1. Side effects associated with the vaccine and treatment
3.1.3. Market Opportunities
3.1.3.1. Advancements in vaccine development activities
Chapter 4. Global Monkeypox Vaccine and Treatment Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Monkeypox Vaccine and Treatment Market, by Product
6.1. Market Snapshot
6.2. Global Monkeypox Vaccine and Treatment Market by Product, Performance - Potential Analysis
6.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Product 2019-2029 (USD Million)
6.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
6.4.1. Vaccine
6.4.2. Drugs
6.4.3. Vaccinia Immune Globulin (VIG)
Chapter 7. Global Monkeypox Vaccine and Treatment Market, by Gender
7.1. Market Snapshot
7.2. Global Monkeypox Vaccine and Treatment Market by Gender, Performance - Potential Analysis
7.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Gender 2019-2029 (USD Million)
7.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
7.4.1. Male
7.4.2. Female
7.4.3. Others
Chapter 8. Global Monkeypox Vaccine and Treatment Market, by Route of Administration
8.1. Market Snapshot
8.2. Global Monkeypox Vaccine and Treatment Market by Route of Administration, Performance - Potential Analysis
8.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Million)
8.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
8.4.1. Oral
8.4.2. Injectables
Chapter 9. Global Monkeypox Vaccine and Treatment Market, by End Use
9.1. Market Snapshot
9.2. Global Monkeypox Vaccine and Treatment Market by End Use, Performance - Potential Analysis
9.3. Global Monkeypox Vaccine and Treatment Market Estimates & Forecasts by End Use 2019-2029 (USD Million)
9.4. Monkeypox Vaccine and Treatment Market, Sub Segment Analysis
9.4.1. Hospitals
9.4.2. Specialty Clinics
9.4.3. Others
Chapter 10. Global Monkeypox Vaccine and Treatment Market, Regional Analysis
10.1. Monkeypox Vaccine and Treatment Market, Regional Market Snapshot
10.2. North America Monkeypox Vaccine and Treatment Market
10.2.1. U.S. Monkeypox Vaccine and Treatment Market
10.2.1.1. Product breakdown estimates & forecasts, 2019-2029
10.2.1.2. Gender breakdown estimates & forecasts, 2019-2029
10.2.1.3. ijkl breakdown estimates & forecasts, 2019-2029
10.2.1.4. End Use breakdown estimates & forecasts, 2019-2029
10.2.2. Canada Monkeypox Vaccine and Treatment Market
10.3. Europe Monkeypox Vaccine and Treatment Market Snapshot
10.3.1. U.K. Monkeypox Vaccine and Treatment Market
10.3.2. Germany Monkeypox Vaccine and Treatment Market
10.3.3. France Monkeypox Vaccine and Treatment Market
10.3.4. Spain Monkeypox Vaccine and Treatment Market
10.3.5. Italy Monkeypox Vaccine and Treatment Market
10.3.6. Rest of Europe Monkeypox Vaccine and Treatment Market
10.4. Asia-Pacific Monkeypox Vaccine and Treatment Market Snapshot
10.4.1. China Monkeypox Vaccine and Treatment Market
10.4.2. India Monkeypox Vaccine and Treatment Market
10.4.3. Japan Monkeypox Vaccine and Treatment Market
10.4.4. Australia Monkeypox Vaccine and Treatment Market
10.4.5. South Korea Monkeypox Vaccine and Treatment Market
10.4.6. Rest of Asia Pacific Monkeypox Vaccine and Treatment Market
10.5. Latin America Monkeypox Vaccine and Treatment Market Snapshot
10.5.1. Brazil Monkeypox Vaccine and Treatment Market
10.5.2. Mexico Monkeypox Vaccine and Treatment Market
10.6. Rest of The World Monkeypox Vaccine and Treatment Market
Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Bavarian Nordic
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. SIGA Technologies
11.2.3. Chimerix
11.2.4. Emergent
11.2.5. Gilead Sciences, Inc.
11.2.6. Sanofi SA
11.2.7. Emcure Pharma
11.2.8. Jinan Jinda Pharmaceutical Chemistry Co., Ltd
11.2.9. Reliance Life Sciences
11.2.10. Haffkine Institute
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption